Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid Carcinoma
暂无分享,去创建一个
P. Spanheimer | I. Ganly | R. Wong | M. Capanu | R. Ghossein | R. Tuttle | A. Shaha | J. Chou | B. Untch
[1] Jeffrey E. Lee,et al. Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness , 2017, The Journal of clinical endocrinology and metabolism.
[2] Douglas B. Evans,et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.
[3] M. Kattan,et al. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer , 2015, Annals of Surgical Oncology.
[4] M. Banerjee,et al. The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. , 2014, The Journal of clinical endocrinology and metabolism.
[5] Kathryn J. Rowland,et al. Biochemical Cure after Reoperations for Medullary Thyroid Carcinoma: A Meta-analysis , 2014, Annals of Surgical Oncology.
[6] Herb Chen,et al. Current understanding and management of medullary thyroid cancer. , 2013, The oncologist.
[7] H. Dralle,et al. Surgical management of the lateral neck compartment for metastatic thyroid cancer , 2013, Current opinion in oncology.
[8] H. Dralle,et al. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. , 2010, The Journal of clinical endocrinology and metabolism.
[9] S. Hauptmann,et al. Prediction of lateral lymph node metastases in medullary thyroid cancer , 2008, The British journal of surgery.
[10] S. Hauptmann,et al. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. , 2007, Archives of surgery.
[11] S. Roman,et al. Prognosis of medullary thyroid carcinoma , 2006, Cancer.
[12] F. Kraeber-Bodéré,et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. , 2005, The Journal of clinical endocrinology and metabolism.
[13] K. Owzar,et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. , 2005, The New England journal of medicine.
[14] H. Holzhausen,et al. Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. , 2005, The Journal of clinical endocrinology and metabolism.
[15] H. Dralle,et al. Early malignant progression of hereditary medullary thyroid cancer. , 2003, The New England journal of medicine.
[16] Jeffrey E. Lee,et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. , 2003, Archives of surgery.
[17] R. Hofstra,et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.
[18] D. Clayton,et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC , 1994, Nature Genetics.
[19] P. Goodfellow,et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. , 1993, Human molecular genetics.
[20] J. Ritz,et al. Activation of a novel human transforming gene, ret, by DNA rearrangement , 1985, Cell.
[21] J. Norton,et al. Localization and resection of clinically inapparent medullary carcinoma of the thyroid. , 1980, Surgery.